These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 6182782)

  • 121. [Immunofluorescence study with an autoantinucleolus antiserum from a scleroderma patient as compared with silver staining].
    Young Y
    Shi Yan Sheng Wu Xue Bao; 1986 Mar; 19(1):39-51. PubMed ID: 2426879
    [No Abstract]   [Full Text] [Related]  

  • 122. Methanol-fixed paraffin-embedded bovine and human epidermis for antinuclear antibodies.
    Guss SB; Ugel AR
    Arch Dermatol; 1972 Nov; 106(5):674-7. PubMed ID: 4564453
    [No Abstract]   [Full Text] [Related]  

  • 123. [Standardization of determination of the antinuclear factor (ANF)].
    Drazdáková M
    Dermatol Monatsschr; 1970; 156(6):635-9. PubMed ID: 4929780
    [No Abstract]   [Full Text] [Related]  

  • 124. Antinuclear antibodies and nuclear antigens in rheumatoid synovial fluids.
    Robitaille P; Zvaifler NJ; Tan EM
    Clin Immunol Immunopathol; 1973 Apr; 1(3):385-97. PubMed ID: 4201401
    [No Abstract]   [Full Text] [Related]  

  • 125. An immunofluorescence procedure for the demonstration of antibodies to native, double-stranded DNA and of circulating DNA-anti-DNA complexes.
    Stingl G; Meingassner JG; Swelty P; Knapp W
    Clin Immunol Immunopathol; 1976 Sep; 6(2):131-40. PubMed ID: 786523
    [No Abstract]   [Full Text] [Related]  

  • 126. [Preparation of a standard for antinuclear antibodies].
    Savitskaia KI; Shakhanina KL; Karmysheva VIa; Rakhinskaia MN
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Nov; (11):68-73. PubMed ID: 339616
    [TBL] [Abstract][Full Text] [Related]  

  • 127. A modified procedure for the detection of antinuclear factor using human leukocytes.
    Dreessen G; Haven G; Halbridge N
    Am J Clin Pathol; 1972 Apr; 57(4):463-6. PubMed ID: 4552044
    [No Abstract]   [Full Text] [Related]  

  • 128. [Antinuclear antibodies in patients with rheumatoid arthritis].
    Wranicz A; Budźko T
    Pol Tyg Lek; 1970 Oct; 25(42):1570-3. PubMed ID: 4920352
    [No Abstract]   [Full Text] [Related]  

  • 129. Immunofluorescent reaction of human chromosomes with certain sera from the patients with systemic lupus erythematosus.
    Yamakami K
    Osaka City Med J; 1973; 19(1):27-35. PubMed ID: 4592762
    [No Abstract]   [Full Text] [Related]  

  • 130. Antigenicity of the nuclei of human leucocytes.
    Zitnan D; Cebecauer L
    Folia Biol (Praha); 1968; 14(3):215-21. PubMed ID: 4873467
    [No Abstract]   [Full Text] [Related]  

  • 131. The "true speckled" antinuclear antibody (ANA) pattern: its tumultuous history.
    Burnham TK; Kleinsmith DM
    Semin Arthritis Rheum; 1983 Nov; 13(2):155-9. PubMed ID: 6369542
    [No Abstract]   [Full Text] [Related]  

  • 132. [Examination of antibodies against nucleoprotein using the "spot" test and its comparison with the usual antinuclear factor determination].
    Kratochvil F; Vlasín Z
    Vnitr Lek; 1971 Dec; 17(12):1155-9. PubMed ID: 4944712
    [No Abstract]   [Full Text] [Related]  

  • 133. Studies on endothelial cell cytotoxic activity in sera of patients with progressive systemic sclerosis, Raynaud syndrome, rheumatoid arthritis, and systemic lupus erythematosus.
    Drenk F; Mensing H; Serbin A; Deicher H
    Rheumatol Int; 1985; 5(6):259-63. PubMed ID: 3880181
    [TBL] [Abstract][Full Text] [Related]  

  • 134. [Correlation of the incidence of LE cells and antinuclear factors in the blood in rheumatoid arthritis].
    Vojtísek O; Bardfeld R
    Fysiatr Revmatol Vestn; 1974 Apr; 52(2):76-80. PubMed ID: 4133908
    [No Abstract]   [Full Text] [Related]  

  • 135. [Characterization of the antinuclear factors revealed by immunofluorescence].
    Bonomo L; Tursi A; Dammacco F
    Reumatismo; 1965; 17(3):119-22. PubMed ID: 5848482
    [No Abstract]   [Full Text] [Related]  

  • 136. Delayed hypersensitivity to DNA in systemic lupus erythematosus and related diseases.
    Svejcar J; Rovenský J; Pekárek J; Zitńan D; Cebecauer L
    Z Immunitatsforsch Exp Klin Immunol; 1974 Dec; 148(3):244-53. PubMed ID: 4283038
    [No Abstract]   [Full Text] [Related]  

  • 137. [Bullous erythema multiforme accompanying lupus erythematosus in the light of immunofluorescent investigations].
    Jablońska S; Blaszczyk M; Jarzabek M
    Przegl Dermatol; 1970; 57(4):437-45. PubMed ID: 4917559
    [No Abstract]   [Full Text] [Related]  

  • 138. [Comparative study and importance of 3 technics for research of anti-DNA antibdoies. (Immunofluorescence on the Trypanosoma gambieuse nucleus, complement fixation, test conditioned hemagglutination)].
    Monier JC; Thivolet J; Sepetjian M
    Ann Inst Pasteur (Paris); 1968 Sep; 115(3):403-15. PubMed ID: 4886013
    [No Abstract]   [Full Text] [Related]  

  • 139. Precipitin reaction between mucopeptide of group A streptococci and human sera (preliminary communication).
    Zitnan D; Cebecauer L; Rotta J
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):168-71. PubMed ID: 5463709
    [No Abstract]   [Full Text] [Related]  

  • 140. Lupus patients who lack detectable anti-DNA: clinical features and survival.
    Ballou SP; Kushner I
    Arthritis Rheum; 1982 Sep; 25(9):1126-9. PubMed ID: 6982045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.